Form 4: Invivyd Director Christine Lindenboom Acquires 50,000 Stock Options
SEC Filing (Form 4)
Christine Lindenboom, a director at Invivyd, Inc., acquired 50,000 stock options on May 21, 2024, as reported in a Form 4 filing with the SEC.
Summary
- Christine Lindenboom, a director of Invivyd, Inc., filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on May 21, 2024, where Ms. Lindenboom acquired 50,000 stock options.
- The exercise price of the stock options is $2.21.
- The options vest in full on the earlier of May 21, 2025, or the date of the Issuer's 2025 Annual Meeting of Stockholders, contingent upon continuous service.
- The expiration date for these options is May 20, 2034.
- Following the reported transaction, Ms. Lindenboom directly owns 50,000 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock option grants to a director. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of stock option grant. |
| 05/21/2025 | First possible vesting date of the stock options. |
| 05/20/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.